NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 35 filers reported holding NOVARTIS A G in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,602 | -5.9% | 55 | -6.8% | 0.01% | +25.0% |
| Q2 2023 | $5,954 | +9.7% | 59 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $5,428 | -15.7% | 59 | -16.9% | 0.00% | -20.0% |
| Q4 2022 | $6,441 | +28.8% | 71 | 0.0% | 0.01% | +25.0% |
| Q3 2022 | $5,000 | -16.7% | 71 | -5.3% | 0.00% | -20.0% |
| Q2 2022 | $6,000 | -14.3% | 75 | 0.0% | 0.01% | 0.0% |
| Q1 2022 | $7,000 | +40.0% | 75 | +25.0% | 0.01% | +66.7% |
| Q4 2021 | $5,000 | +25.0% | 60 | +27.7% | 0.00% | 0.0% |
| Q3 2021 | $4,000 | 0.0% | 47 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $4,000 | 0.0% | 47 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $4,000 | -20.0% | 47 | -13.0% | 0.00% | -25.0% |
| Q4 2020 | $5,000 | -61.5% | 54 | -63.0% | 0.00% | -66.7% |
| Q3 2020 | $13,000 | 0.0% | 146 | 0.0% | 0.01% | -14.3% |
| Q2 2020 | $13,000 | +225.0% | 146 | +147.5% | 0.01% | +180.0% |
| Q1 2020 | $4,000 | -20.0% | 59 | -1.7% | 0.01% | 0.0% |
| Q4 2019 | $5,000 | – | 60 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MANAGED ASSET PORTFOLIOS, LLC | 332,962 | $27,452,000 | 7.32% |
| Mawer Investment Management Ltd. | 7,721,327 | $636,623,000 | 5.86% |
| Martin Investment Management, LLC | 133,246 | $10,986,000 | 5.56% |
| SCHARF INVESTMENTS, LLC | 1,330,175 | $109,673,000 | 5.48% |
| Hansberger Growth Investors, LP | 46,663 | $3,847,000 | 5.19% |
| Bain Capital Public Equity Management II, LLC | 440,233 | $36,297,000 | 4.25% |
| First Fiduciary Investment Counsel, Inc. | 187,633 | $15,470,000 | 4.10% |
| GARLAND CAPITAL MANAGEMENT INC | 53,555 | $4,416,000 | 4.02% |
| Lowell Blake & Associates Inc. | 37,219 | $3,069,000 | 3.94% |
| PRENTISS SMITH & CO INC | 68,027 | $5,609,000 | 3.89% |